Preclinical Studies and Translational Applications of Intracerebral Hemorrhage
- PMID: 28698874
- PMCID: PMC5494071
- DOI: 10.1155/2017/5135429
Preclinical Studies and Translational Applications of Intracerebral Hemorrhage
Abstract
Intracerebral hemorrhage (ICH) which refers to bleeding in the brain is a very deleterious condition with high mortality and disability rate. Surgery or conservative therapy remains the treatment option. Various studies have divided the disease process of ICH into primary and secondary injury, for which knowledge into these processes has yielded many preclinical and clinical treatment options. The aim of this review is to highlight some of the new experimental drugs as well as other treatment options like stem cell therapy, rehabilitation, and nanomedicine and mention some translational clinical applications that have been done with these treatment options.
Figures
References
-
- Mendelow A. D., Gregson B. A., Fernandes H. M., et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. The Lancet. 2005;365(9457):387–397. doi: 10.1016/s0140-6736(05)17826-x. - DOI - PubMed
-
- Mendelow A. D., Gregson B. A., Rowan E. N., Murray G. D., Gholkar A., Mitchell P. M. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. The Lancet. 2013;382(9890):397–408. doi: 10.1016/s0140-6736(13)60986-1. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
